Palantir added 69 cents of GAAP operating income for each new revenue dollar in the latest year. Goldman's $230 target ...

Iambic's $15 to $17 IPO range is below its April round. At the $16 midpoint, $66.5 million of notes convert into 4.95 million ...

Krishnan is seeking $500 million for a national-security fund. Shield Capital reported 33 percent of its second fund's target ...

The SEC exemption caps trading in tokenized large-cap stocks at 0.25 percent of daily volume and allows issuers to object ...

Amazon's 8 percent share in Q2 2025 reflected a tariff-driven pull-forward. Against 2024, shipments are down about a third in ...

Starbucks has explored a Chipotle takeover. Borrowing $20 billion would raise leverage to about 4 times. An all-stock deal ...

Amazon's receivables rose $30.7 billion in a year. Customer balances explain $12.6 billion; other receivables nearly tripled ...

Oratomic's reported $5.4 billion valuation means $475 million buys 8.8 percent, compared with 20 percent for $300 million in ...

At least 68,000 people were exposed across seven or more South Korean financial institutions. CrowdStrike says ARTEX ran ...

Crescent's estimated net $3.85 billion price equals 3.1 times the Eagle Ford's annualised first-half 2026 revenue less direct costs, 3.8 times the latest twelve ...

AT&T may cut its panel from about 30 law firms to 18 or 20. Each survivor would gain share, but would earn more only if total outside legal spending falls by le ...

The Phase 3 UNITY stop erased about $8 billion in value from argenx. Investors now face a similar efficacy question in Immunovant's Week 24 Sjögren's trial.